Last week, Tempdrop presented at The 1st Congress on Women's Health Innovations and Inventions in Tel Aviv, Israel. The focus of the conference was "Addressing Unmet Clinical Needs."
The title of our talk was "Bridging Each Woman's Cycle & The Health Apps or Services She Uses With Accurate Data."
In the talk, Founder & CEO Michael Vardi talked about the problem with traditional basal body temperature thermometers and how the technology behind Tempdrop allows it to generate clear fertility awareness charts no matter cycle regularity, sleeping patterns, or environmental variables.
But the larger message of Tempdrop is that it connects fertility and digital health, giving women a portal to see their fertility and overall health at a glimpse. While we've started with basal body temperature and sleep, we plan to incorporate other important metrics that will become a foundation for health tracking, diagnosis, and treatment.
Besides the talk, one of our research abstracts was selected for display and WHII served as a first opportunity for us to present ongoing research on cycle analysis. Our research abstract was entitled, "Calculation and Identification of Various Cycle Phases, By Analyzing Data from a Novel, Non-invasive, Sleeping Temperature Sensor with Temperature Patterns Learning Capabilities."
The research was a joint effect between Michael, our CTO Yaniv Shpaichler, and long-time Tempdrop user and Data Analyst Liza Pattarson. Tempdrop was presented as an alternative to basal body thermometers that require early morning wake-ups and are subject to other errors and environmental factors that skew accuracy.
The purpose of the presentation was to share a set of temperature rules that define the different phases of the cycle and to demonstrate the effectiveness of a novel, axillary temperature sensor - Tempdrop, of course - in achieving those temperatures seamlessly and accurately.
The research was based on anonymized temperature data from 4,789 women wearing the Tempdrop sensor during sleep from 15 to 657 days and contained a total of 935,759 sleep sessions spread over 2 years.
In the presentation, we covered our methodology for identifying different phases of the cycle and also showed Tempdrop's ability to identify the luteal and follicular phases of the cycle, ovulation and menstruation, in addition to ovulation with PCOS and pregnancy complications.
The results demonstrated clear correlation between practice and theory of temperature variations throughout various cycle phases. Future studies will explore how predicting ovulation based on pre-ovulation patterns and diagnosing various medical conditions by identifying temperature abnormalities.
Here is our CTO, Yaniv Shpaichler, next to our poster presentation at WHII.
We just celebrated our second birthday since shipping and WHII was an important milestone because it shows that in addition to being a fertility tool, Tempdrop is also a research company. As part of our mission to elevate women's health, it is our priority to conduct research and share its ongoing results. This is just the beginning!